In this study, we conducted an in-depth exploration of the clinicopathological characteristics, prognostic implications, and diagnostic potential of EMP3 in glioblastoma patients, employing both bulk and single-cell analysis methods. This evidence concerns the gene EMP3 and glioblastoma.